Where authorisation for initial or continuing access to the supply of product has been declined by the Authoriser, the application may be reconsidered if there are subsequent changes to the patient’s clinical circumstances such that they become eligible for access (e.g. further clarification of the diagnosis and/or changes in their clinical condition). In those states and territories that choose to be involved in decisions for authorisation of initial access to treatment, continuing treatment or cessation of treatment, a mechanism may be established to refer decisions for consideration by the state/territory health department or jurisdictional committee, as appropriate. 5.5 Dispensing The dispensing of immunoglobulin can only be made by the business unit designated by a hospital/health facility as having the ordering and inventory management responsibility for immunoglobulin (the Dispenser). The designated business unit must have the management competencies, facilities and appropriate endorsement commensurate with managing a high-cost product. Generally, this will be the health provider blood bank, pathology laboratory or pharmacy, either in-house or under third party provider arrangements. The Dispenser is responsible for product ordering, inventory management and dispensing product for use in accordance with the access arrangements. The Dispenser will only issue immunoglobulin against requirements authorised in BloodSTAR. Product ordering by the Dispenser will be through BloodNet (or an alternative arrangement if necessary) as stock orders based on clinical demand for authorised patients, and with consideration of stock on hand. The product ordering and dispensing process is trial at Figure 2 Product ordering and – dispensing process diagram. PRODUCT ORDERING AND DISPENSING PREPARE NOTIFIED PRODUCT ORDER / PLANNING PATIENT SHEET PRODUCT SCHEDULED TO SUBMIT PATIENTS DISPENSE NO CHECK PATIENT PATIENT AUTHORISATION AUTHORISED IN BLOODSTAR IN YES YES BLOODSTAR? SSHHEEEETT RECEIPT PRODUCT CHECK NO RECEIVE LEVELS DISPENSE AGAINST STOCK REQUEST PLANNED ON (BLOODSTAR) HAND? DISPENSE SUBMIT RECONCILE BLOODNET DISPENSE ORDER AGAINST AUTHORISATION RECEIPT FULFIL ORDER Figure 2 Product ordering and dispensing process diagram. –
Where authorisation for initial or continuing access to the supply of product has been declined by the Authoriser, the application may be reconsidered if there are subsequent changes to the patient’s clinical circumstances such that they become eligible for access (e.g. further clarification of the diagnosis and/or changes in their clinical condition). In those states and territories that choose to be involved in decisions for authorisation of initial access to treatment, continuing treatment or cessation of treatment, a mechanism may be established to refer decisions for consideration by the state/territory health department or jurisdictional committee, as appropriate. 5.5 Dispensing The dispensing of immunoglobulin can only be made by the business unit designated by a hospital/health facility as having the ordering and inventory management responsibility for immunoglobulin (the Dispenser). The designated business unit must have the management competencies, facilities and appropriate endorsement commensurate with managing a high-cost product. Generally, this will be the health provider blood bank, pathology laboratory or pharmacy, either in-house or under third party provider arrangements. The Dispenser is responsible for product ordering, inventory management and dispensing product for use in accordance with the access arrangements. The Dispenser will only issue immunoglobulin against requirements authorised in BloodSTAR. Product ordering by the Dispenser will be through BloodNet (or an alternative arrangement if necessary) as stock orders based on clinical demand for authorised patients, and with consideration of stock on hand. The product ordering and dispensing process is at Figure 2 – Product ordering and dispensing process diagram. PRODUCT ORDERING AND DISPENSING PATIENT SCHEDULED PREPARE PRODUCT ORDER / PLANNING SHEET SUBMIT DISPENSE NOTIFIED PRODUCT TO PATIENTS NO SSHHEEEETT CHECK PATIENT AUTHORISATION IN BLOODSTAR PATIENT AUTHORISED IN BLOODSTAR? YES YES RECEIVE DISPENSE REQUEST (BLOODSTAR) CHECK LEVELS AGAINST PLANNED STOCK ON HAND? NO RECEIPT PRODUCT DISPENSE SUBMIT BLOODNET ORDER RECONCILE DISPENSE AGAINST AUTHORISATION RECEIPT FULFIL ORDER Figure 2 – Product ordering and dispensing process diagram. trial